nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—liver cancer—retroperitoneal cancer	0.584	0.638	CtDrD
Sorafenib—kidney cancer—retroperitoneal cancer	0.332	0.362	CtDrD
Sorafenib—STK10—renal vein—retroperitoneal cancer	0.0125	0.15	CbGeAlD
Sorafenib—STK10—renal artery—retroperitoneal cancer	0.00839	0.101	CbGeAlD
Sorafenib—KDR—appendage—retroperitoneal cancer	0.00205	0.0245	CbGeAlD
Sorafenib—MUSK—testis—retroperitoneal cancer	0.00181	0.0217	CbGeAlD
Sorafenib—CDKL3—testis—retroperitoneal cancer	0.00161	0.0193	CbGeAlD
Sorafenib—CDKL2—testis—retroperitoneal cancer	0.00147	0.0177	CbGeAlD
Sorafenib—MAPK15—testis—retroperitoneal cancer	0.00133	0.0159	CbGeAlD
Sorafenib—HTR2C—ganglion—retroperitoneal cancer	0.00105	0.0125	CbGeAlD
Sorafenib—HIPK3—kidney—retroperitoneal cancer	0.000979	0.0117	CbGeAlD
Sorafenib—MAPK11—adrenal gland—retroperitoneal cancer	0.000952	0.0114	CbGeAlD
Sorafenib—CDK7—adrenal gland—retroperitoneal cancer	0.000936	0.0112	CbGeAlD
Sorafenib—TAOK2—adrenal gland—retroperitoneal cancer	0.000929	0.0111	CbGeAlD
Sorafenib—AURKC—adrenal gland—retroperitoneal cancer	0.000922	0.011	CbGeAlD
Sorafenib—HIPK4—testis—retroperitoneal cancer	0.000893	0.0107	CbGeAlD
Sorafenib—ZAK—adrenal gland—retroperitoneal cancer	0.000809	0.00969	CbGeAlD
Sorafenib—HIPK3—adrenal gland—retroperitoneal cancer	0.000792	0.00949	CbGeAlD
Sorafenib—MAPK11—testis—retroperitoneal cancer	0.000787	0.00943	CbGeAlD
Sorafenib—CDK7—testis—retroperitoneal cancer	0.000774	0.00927	CbGeAlD
Sorafenib—TAOK2—testis—retroperitoneal cancer	0.000768	0.0092	CbGeAlD
Sorafenib—UGT1A9—kidney—retroperitoneal cancer	0.000767	0.00919	CbGeAlD
Sorafenib—AURKC—testis—retroperitoneal cancer	0.000762	0.00913	CbGeAlD
Sorafenib—TIE1—adrenal gland—retroperitoneal cancer	0.00074	0.00886	CbGeAlD
Sorafenib—BRAF—adrenal gland—retroperitoneal cancer	0.000709	0.0085	CbGeAlD
Sorafenib—EPHA6—testis—retroperitoneal cancer	0.000706	0.00846	CbGeAlD
Sorafenib—EPHX2—adrenal gland—retroperitoneal cancer	0.000678	0.00812	CbGeAlD
Sorafenib—FLT3—adrenal gland—retroperitoneal cancer	0.000673	0.00807	CbGeAlD
Sorafenib—ZAK—testis—retroperitoneal cancer	0.000669	0.00802	CbGeAlD
Sorafenib—RET—kidney—retroperitoneal cancer	0.000668	0.008	CbGeAlD
Sorafenib—HIPK3—testis—retroperitoneal cancer	0.000655	0.00784	CbGeAlD
Sorafenib—MAP3K19—testis—retroperitoneal cancer	0.000642	0.00768	CbGeAlD
Sorafenib—RALBP1—kidney—retroperitoneal cancer	0.000618	0.00741	CbGeAlD
Sorafenib—TIE1—testis—retroperitoneal cancer	0.000612	0.00733	CbGeAlD
Sorafenib—FLT4—adrenal gland—retroperitoneal cancer	0.000612	0.00733	CbGeAlD
Sorafenib—FGFR1—adrenal gland—retroperitoneal cancer	0.000603	0.00723	CbGeAlD
Sorafenib—FLT1—kidney—retroperitoneal cancer	0.000588	0.00705	CbGeAlD
Sorafenib—BRAF—testis—retroperitoneal cancer	0.000587	0.00703	CbGeAlD
Sorafenib—RAF1—kidney—retroperitoneal cancer	0.000585	0.007	CbGeAlD
Sorafenib—MAP3K7—adrenal gland—retroperitoneal cancer	0.000571	0.00684	CbGeAlD
Sorafenib—MAPK11—lymph node—retroperitoneal cancer	0.00057	0.00683	CbGeAlD
Sorafenib—CDK7—lymph node—retroperitoneal cancer	0.000561	0.00672	CbGeAlD
Sorafenib—EPHX2—testis—retroperitoneal cancer	0.000561	0.00672	CbGeAlD
Sorafenib—FLT3—testis—retroperitoneal cancer	0.000557	0.00667	CbGeAlD
Sorafenib—TAOK2—lymph node—retroperitoneal cancer	0.000557	0.00667	CbGeAlD
Sorafenib—STK10—kidney—retroperitoneal cancer	0.000557	0.00667	CbGeAlD
Sorafenib—MKNK2—adrenal gland—retroperitoneal cancer	0.000554	0.00663	CbGeAlD
Sorafenib—AURKC—lymph node—retroperitoneal cancer	0.000552	0.00662	CbGeAlD
Sorafenib—MKNK1—adrenal gland—retroperitoneal cancer	0.000547	0.00655	CbGeAlD
Sorafenib—RET—adrenal gland—retroperitoneal cancer	0.00054	0.00647	CbGeAlD
Sorafenib—UGT1A1—kidney—retroperitoneal cancer	0.000526	0.0063	CbGeAlD
Sorafenib—FLT4—testis—retroperitoneal cancer	0.000506	0.00606	CbGeAlD
Sorafenib—RALBP1—adrenal gland—retroperitoneal cancer	0.0005	0.00599	CbGeAlD
Sorafenib—FGFR1—testis—retroperitoneal cancer	0.000499	0.00598	CbGeAlD
Sorafenib—KDR—kidney—retroperitoneal cancer	0.000497	0.00596	CbGeAlD
Sorafenib—ZAK—lymph node—retroperitoneal cancer	0.000485	0.00581	CbGeAlD
Sorafenib—FLT1—adrenal gland—retroperitoneal cancer	0.000475	0.0057	CbGeAlD
Sorafenib—HIPK3—lymph node—retroperitoneal cancer	0.000475	0.00569	CbGeAlD
Sorafenib—RAF1—adrenal gland—retroperitoneal cancer	0.000473	0.00566	CbGeAlD
Sorafenib—MAP3K7—testis—retroperitoneal cancer	0.000472	0.00566	CbGeAlD
Sorafenib—EPHB6—adrenal gland—retroperitoneal cancer	0.00047	0.00563	CbGeAlD
Sorafenib—MKNK2—testis—retroperitoneal cancer	0.000458	0.00548	CbGeAlD
Sorafenib—MKNK1—testis—retroperitoneal cancer	0.000452	0.00541	CbGeAlD
Sorafenib—STK10—adrenal gland—retroperitoneal cancer	0.00045	0.00539	CbGeAlD
Sorafenib—RET—testis—retroperitoneal cancer	0.000446	0.00535	CbGeAlD
Sorafenib—PDGFRA—adrenal gland—retroperitoneal cancer	0.000446	0.00534	CbGeAlD
Sorafenib—TIE1—lymph node—retroperitoneal cancer	0.000444	0.00531	CbGeAlD
Sorafenib—KIT—kidney—retroperitoneal cancer	0.000441	0.00528	CbGeAlD
Sorafenib—PDGFRB—kidney—retroperitoneal cancer	0.00043	0.00515	CbGeAlD
Sorafenib—BRAF—lymph node—retroperitoneal cancer	0.000425	0.00509	CbGeAlD
Sorafenib—RALBP1—testis—retroperitoneal cancer	0.000413	0.00495	CbGeAlD
Sorafenib—EPHX2—lymph node—retroperitoneal cancer	0.000406	0.00487	CbGeAlD
Sorafenib—FLT3—lymph node—retroperitoneal cancer	0.000404	0.00483	CbGeAlD
Sorafenib—KDR—adrenal gland—retroperitoneal cancer	0.000402	0.00481	CbGeAlD
Sorafenib—MAP2K5—adrenal gland—retroperitoneal cancer	0.000402	0.00481	CbGeAlD
Sorafenib—FLT1—testis—retroperitoneal cancer	0.000393	0.00471	CbGeAlD
Sorafenib—CSF1R—adrenal gland—retroperitoneal cancer	0.000392	0.0047	CbGeAlD
Sorafenib—RAF1—testis—retroperitoneal cancer	0.000391	0.00468	CbGeAlD
Sorafenib—EPHB6—testis—retroperitoneal cancer	0.000389	0.00466	CbGeAlD
Sorafenib—STK10—testis—retroperitoneal cancer	0.000372	0.00446	CbGeAlD
Sorafenib—PDGFRA—testis—retroperitoneal cancer	0.000368	0.00441	CbGeAlD
Sorafenib—FLT4—lymph node—retroperitoneal cancer	0.000367	0.00439	CbGeAlD
Sorafenib—FGFR1—lymph node—retroperitoneal cancer	0.000362	0.00433	CbGeAlD
Sorafenib—KIT—adrenal gland—retroperitoneal cancer	0.000356	0.00427	CbGeAlD
Sorafenib—PDGFRB—adrenal gland—retroperitoneal cancer	0.000348	0.00417	CbGeAlD
Sorafenib—ABCC4—kidney—retroperitoneal cancer	0.000343	0.0041	CbGeAlD
Sorafenib—MAP3K7—lymph node—retroperitoneal cancer	0.000342	0.0041	CbGeAlD
Sorafenib—KDR—testis—retroperitoneal cancer	0.000332	0.00398	CbGeAlD
Sorafenib—MAP2K5—testis—retroperitoneal cancer	0.000332	0.00398	CbGeAlD
Sorafenib—MKNK2—lymph node—retroperitoneal cancer	0.000332	0.00397	CbGeAlD
Sorafenib—ABCC2—kidney—retroperitoneal cancer	0.000332	0.00397	CbGeAlD
Sorafenib—MKNK1—lymph node—retroperitoneal cancer	0.000328	0.00392	CbGeAlD
Sorafenib—CSF1R—testis—retroperitoneal cancer	0.000324	0.00389	CbGeAlD
Sorafenib—RET—lymph node—retroperitoneal cancer	0.000324	0.00388	CbGeAlD
Sorafenib—RALBP1—lymph node—retroperitoneal cancer	0.0003	0.00359	CbGeAlD
Sorafenib—KIT—testis—retroperitoneal cancer	0.000295	0.00353	CbGeAlD
Sorafenib—PDGFRB—testis—retroperitoneal cancer	0.000288	0.00345	CbGeAlD
Sorafenib—FLT1—lymph node—retroperitoneal cancer	0.000285	0.00341	CbGeAlD
Sorafenib—RAF1—lymph node—retroperitoneal cancer	0.000283	0.00339	CbGeAlD
Sorafenib—EPHB6—lymph node—retroperitoneal cancer	0.000282	0.00337	CbGeAlD
Sorafenib—ABCC4—adrenal gland—retroperitoneal cancer	0.000277	0.00332	CbGeAlD
Sorafenib—HTR2B—adrenal gland—retroperitoneal cancer	0.000276	0.0033	CbGeAlD
Sorafenib—STK10—lymph node—retroperitoneal cancer	0.00027	0.00323	CbGeAlD
Sorafenib—ABCC2—adrenal gland—retroperitoneal cancer	0.000268	0.00321	CbGeAlD
Sorafenib—PDGFRA—lymph node—retroperitoneal cancer	0.000267	0.0032	CbGeAlD
Sorafenib—CYP2C8—kidney—retroperitoneal cancer	0.000249	0.00298	CbGeAlD
Sorafenib—MAP2K5—lymph node—retroperitoneal cancer	0.000241	0.00289	CbGeAlD
Sorafenib—KDR—lymph node—retroperitoneal cancer	0.000241	0.00289	CbGeAlD
Sorafenib—CSF1R—lymph node—retroperitoneal cancer	0.000235	0.00282	CbGeAlD
Sorafenib—ABCC4—testis—retroperitoneal cancer	0.000229	0.00274	CbGeAlD
Sorafenib—CYP3A5—kidney—retroperitoneal cancer	0.000225	0.00269	CbGeAlD
Sorafenib—CYP2B6—kidney—retroperitoneal cancer	0.000223	0.00267	CbGeAlD
Sorafenib—ABCC2—testis—retroperitoneal cancer	0.000222	0.00266	CbGeAlD
Sorafenib—KIT—lymph node—retroperitoneal cancer	0.000214	0.00256	CbGeAlD
Sorafenib—PDGFRB—lymph node—retroperitoneal cancer	0.000209	0.0025	CbGeAlD
Sorafenib—ABCG2—adrenal gland—retroperitoneal cancer	0.000196	0.00234	CbGeAlD
Sorafenib—CYP2B6—adrenal gland—retroperitoneal cancer	0.00018	0.00216	CbGeAlD
Sorafenib—CYP3A4—kidney—retroperitoneal cancer	0.000168	0.00202	CbGeAlD
Sorafenib—CYP2C8—testis—retroperitoneal cancer	0.000166	0.00199	CbGeAlD
Sorafenib—ABCC4—lymph node—retroperitoneal cancer	0.000166	0.00199	CbGeAlD
Sorafenib—CYP2D6—kidney—retroperitoneal cancer	0.000166	0.00199	CbGeAlD
Sorafenib—HTR2B—lymph node—retroperitoneal cancer	0.000165	0.00198	CbGeAlD
Sorafenib—ABCG2—testis—retroperitoneal cancer	0.000162	0.00194	CbGeAlD
Sorafenib—ABCC2—lymph node—retroperitoneal cancer	0.000161	0.00193	CbGeAlD
Sorafenib—CYP2B6—testis—retroperitoneal cancer	0.000149	0.00179	CbGeAlD
Sorafenib—ABCB1—kidney—retroperitoneal cancer	0.000119	0.00143	CbGeAlD
Sorafenib—ABCG2—lymph node—retroperitoneal cancer	0.000117	0.0014	CbGeAlD
Sorafenib—CYP2D6—testis—retroperitoneal cancer	0.000111	0.00133	CbGeAlD
Sorafenib—ABCB1—adrenal gland—retroperitoneal cancer	9.64e-05	0.00116	CbGeAlD
Sorafenib—ABCB1—testis—retroperitoneal cancer	7.97e-05	0.000955	CbGeAlD
Sorafenib—ABCB1—lymph node—retroperitoneal cancer	5.78e-05	0.000692	CbGeAlD
